Kahn Brothers Group now holds twice as many Pfizer shares, as it does Merck shares. The institutional investor sold some 17,000 shares of Merck in the third quarter, while it bought up some 182,000 Pfizer shares. See this smallish Bloomberg item; or read the Kahn Brothers Group's SEC filing, just uploaded this morning.:
. . . .MRK: $54 million | sold 17,563 shares | PFE: $48 million | bought 182,855 shares. . . .
